Refoxy Pharma
Biotechnology company developing stress response pathway modulators for longevity therapeutics, focusing on the oxidative stress response to treat age-related diseases.
Website
https://www.refoxypharma.comLocation
Berlin, Germany
Founded
2020
Investors
1
Categories
biotech, therapeutics, longevity, stress-response
Notes
Refoxy Pharma is a biotechnology company based in Berlin, Germany, focused on developing therapeutics that modulate stress response pathways to promote healthy aging and longevity. The company's approach targets the body's natural stress response mechanisms, particularly oxidative stress pathways, to develop treatments for age-related diseases.
The company is part of the Apollo Health Ventures portfolio, which focuses on longevity and aging-related biotechnology investments.
Team
- Company leadership information not publicly available
Additional Research Findings
- Investor: Apollo Health Ventures
- Focus on stress response pathway modulators
- Longevity therapeutics development
- Based in Berlin, Germany
- Part of the growing European longevity biotech ecosystem
Sources
- Apollo Health Ventures Portfolio
- Company website
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apollo Health Ventures | Dusseldorf, Germany / Boston, USA | biotech-focused | seedseries-a+1 | 15 |